- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy of cancer in 2012
Authors
Keywords
-
Journal
CA-A CANCER JOURNAL FOR CLINICIANS
Volume 62, Issue 5, Pages 309-335
Publisher
American Cancer Society
Online
2012-05-10
DOI
10.3322/caac.20132
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I study of BMS-663513, a fully human anti-CD137 agonist monoclonal antibody, in patients (pts) with advanced cancer (CA)
- (2017) M. Sznol et al. JOURNAL OF CLINICAL ONCOLOGY
- Attenuating Regulatory T Cell Induction by TLR Agonists through Inhibition of p38 MAPK Signaling in Dendritic Cells Enhances Their Efficacy as Vaccine Adjuvants and Cancer Immunotherapeutics
- (2014) A. G. Jarnicki et al. JOURNAL OF IMMUNOLOGY
- Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant
- (2014) S. Adams et al. JOURNAL OF IMMUNOLOGY
- Infiltrated Neutrophils Acquire Novel Chemokine Receptor Expression and Chemokine Responsiveness in Chronic Inflammatory Lung Diseases
- (2014) D. Hartl et al. JOURNAL OF IMMUNOLOGY
- Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors
- (2011) Jens Rüter et al. CANCER BIOLOGY & THERAPY
- Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
- (2011) L. H. Butterfield et al. CLINICAL CANCER RESEARCH
- Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer
- (2011) T. M. Beer et al. CLINICAL CANCER RESEARCH
- Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma
- (2011) Ahmad A. Tarhini et al. JOURNAL OF CLINICAL ONCOLOGY
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Presence of Tumor-Infiltrating Lymphocytes and a Dominant Nodule Within Primary Melanoma Are Prognostic Factors for Relapse-Free Survival of Patients With Thick (T4) Primary Melanoma
- (2010) Uma N. M. Rao et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response
- (2010) R. Abes et al. BLOOD
- Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma
- (2010) Ryosuke Hino et al. CANCER
- Adoptive Cell Therapy
- (2010) Richard A. Morgan et al. CANCER JOURNAL
- Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy
- (2010) J. J. Hong et al. CLINICAL CANCER RESEARCH
- A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma
- (2010) M. Hussein et al. HAEMATOLOGICA
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Antigen–Targeted, Monoclonal Antibody–Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape
- (2010) Robert L. Ferris et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human Tumor Antigen-Specific Helper and Regulatory T Cells Share Common Epitope Specificity but Exhibit Distinct T Cell Repertoire
- (2010) J. Fourcade et al. JOURNAL OF IMMUNOLOGY
- Antibody-Targeted NY-ESO-1 to Mannose Receptor or DEC-205 In Vitro Elicits Dual Human CD8+ and CD4+ T Cell Responses with Broad Antigen Specificity
- (2010) T. Tsuji et al. JOURNAL OF IMMUNOLOGY
- Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis
- (2010) S. Mocellin et al. JNCI-Journal of the National Cancer Institute
- Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force
- (2010) Lisa H Butterfield et al. Journal of Translational Medicine
- A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia
- (2010) Richard R. Furman et al. LEUKEMIA & LYMPHOMA
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polarized dendritic cells as cancer vaccines: Directing effector-type T cells to tumors
- (2010) Pawel Kalinski et al. SEMINARS IN IMMUNOLOGY
- Whole tumor antigen vaccines
- (2010) Cheryl Lai-Lai Chiang et al. SEMINARS IN IMMUNOLOGY
- Biology and Clinical Applications of CD40 in Cancer Treatment
- (2010) Ester Fonsatti et al. SEMINARS IN ONCOLOGY
- Advances in viral-vector systemic cytokine gene therapy against cancer
- (2010) Lihua Liu et al. VACCINE
- Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
- (2009) M. Ahmadzadeh et al. BLOOD
- PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model
- (2009) L. Zhang et al. BLOOD
- Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
- (2009) Celestia S. Higano et al. CANCER
- Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
- (2009) P.-Y. Pan et al. CANCER RESEARCH
- Immunotherapy of Malignant Disease with Tumor Antigen-Specific Monoclonal Antibodies
- (2009) M. Campoli et al. CLINICAL CANCER RESEARCH
- Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial
- (2009) C. L. Slingluff et al. CLINICAL CANCER RESEARCH
- Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/- Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN- 2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
- (2009) J. M. Kirkwood et al. CLINICAL CANCER RESEARCH
- Generation and maintenance of memory CD4+ T Cells
- (2009) Ester MM van Leeuwen et al. CURRENT OPINION IN IMMUNOLOGY
- Emerging therapies in castrate-resistant prostate cancer
- (2009) Kiran Lassi et al. CURRENT OPINION IN ONCOLOGY
- Cellular immunotherapy for ovarian cancer
- (2009) Martin J Cannon et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Ten years of rituximab in NHL
- (2009) Matthew C Winter et al. Expert Opinion On Drug Safety
- Progress and prospects: immune responses to viral vectors
- (2009) S Nayak et al. GENE THERAPY
- The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis
- (2009) Andrea M. Cooper et al. IMMUNOLOGICAL REVIEWS
- Immunotherapy for Prostate Cancer: Walk, Don't Run
- (2009) Charles G. Drake JOURNAL OF CLINICAL ONCOLOGY
- Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
- (2009) Frédéric Bibeau et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma
- (2009) Ranjana Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- CD44high Memory CD8 T Cells Synergize with CpG DNA to Activate Dendritic Cell IL-12p70 Production
- (2009) K. L. Wong et al. JOURNAL OF IMMUNOLOGY
- Independent Regulation of Chemokine Responsiveness and Cytolytic Function versus CD8+ T Cell Expansion by Dendritic Cells
- (2009) P. B. Watchmaker et al. JOURNAL OF IMMUNOLOGY
- PD-1 Is a Regulator of NY-ESO-1-Specific CD8+ T Cell Expansion in Melanoma Patients
- (2009) J. Fourcade et al. JOURNAL OF IMMUNOLOGY
- PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells
- (2009) V. V. Parekh et al. JOURNAL OF IMMUNOLOGY
- Maturation Pathways of Dendritic Cells Determine TAP1 and TAP2 Levels and Cross-presenting Function
- (2009) Andrés López-Albaitero et al. JOURNAL OF IMMUNOTHERAPY
- Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology
- (2009) Hideaki Tahara et al. Journal of Translational Medicine
- Monoclonal antibodies for cancer immunotherapy
- (2009) Louis M Weiner et al. LANCET
- Cetuximab plus chemotherapy in patients with advanced NSCLC
- (2009) Kakil Ibrahim Rasul et al. Nature Reviews Clinical Oncology
- Rethinking therapeutic cancer vaccines
- (2009) NATURE REVIEWS DRUG DISCOVERY
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- B7-H1 (PD-L1) on T cells is required for T-cell-mediated conditioning of dendritic cell maturation
- (2009) Oezcan Talay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cetuximab therapy for patients with advanced squamous cell carcinomas of the head and neck
- (2009) William N William et al. Nature clinical practice. Oncology
- Biweekly cetuximab and irinotecan as third-line therapy in patients with advanced colorectal cancer after failure to irinotecan, oxaliplatin and 5-fluorouracil
- (2008) P. Pfeiffer et al. ANNALS OF ONCOLOGY
- B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells
- (2008) T. Azuma et al. BLOOD
- Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer
- (2008) Celestia S. Higano et al. CANCER
- Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
- (2008) Zhen Fan Yang et al. CANCER CELL
- Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell
- (2008) Xiaojun Yang et al. CANCER LETTERS
- Recruitment and Activation of Natural Killer Cells In vitro by a Human Dendritic Cell Vaccine
- (2008) K. Gustafsson et al. CANCER RESEARCH
- Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during Maturation
- (2008) R. Muthuswamy et al. CANCER RESEARCH
- Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies
- (2008) R. Berger et al. CLINICAL CANCER RESEARCH
- Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
- (2008) Lun Cai et al. CLINICAL IMMUNOLOGY
- Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer
- (2008) Andrew Bottomley et al. EUROPEAN JOURNAL OF CANCER
- Current perspective – Trastuzumab
- (2008) Peter S. Hall et al. EUROPEAN JOURNAL OF CANCER
- Paradigm Shifts in Cancer Vaccine Therapy
- (2008) Jeffrey Schlom et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Cancer Immunotherapy by Dendritic Cells
- (2008) Cornelis J.M. Melief IMMUNITY
- Next Generation of Immunotherapy for Melanoma
- (2008) John M. Kirkwood et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Christian Manegold et al. JOURNAL OF CLINICAL ONCOLOGY
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
- (2008) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunization With Analog Peptide in Combination With CpG and Montanide Expands Tumor Antigen-specific CD8+ T Cells in Melanoma Patients
- (2008) Julien Fourcade et al. JOURNAL OF IMMUNOTHERAPY
- Phase 1 Trial of Intranodal Injection of a Melan-A/MART-1 DNA Plasmid Vaccine in Patients With Stage IV Melanoma
- (2008) Jeffrey Weber et al. JOURNAL OF IMMUNOTHERAPY
- Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia
- (2008) Je-Jung Lee et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"
- (2008) Lisa H Butterfield et al. Journal of Translational Medicine
- Tumour immunity: effector response to tumour and role of the microenvironment
- (2008) Alberto Mantovani et al. LANCET
- Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen
- (2008) D. E. Speiser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells
- (2008) L. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis
- (2008) J. B. Swann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer
- (2008) Gabriella Mariani et al. Nature clinical practice. Oncology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now